High VHL Expression Reverses Warburg Phenotype and Enhances Immunogenicity in Kidney Tumor Cells.
High VHL Expression Reverses Warburg Phenotype and Enhances Immunogenicity in Kidney Tumor Cells.
复制标题
VHL 高表达可逆转 Warburg 表型并增强肾肿瘤细胞的免疫原性
DOI:
10.1016/j.gpb.2019.12.002
复制
发表时间:
2022-08
影响因子:
9.5
通讯作者:
Deng, Haiteng
中科院分区:
文献类型:
--
作者:
Zhu, Songbiao;Ding, Wenxi;Chen, Yuling;Wang, Weixuan;Xu, Renhua;Liu, Chongdong;Liu, Xiaohui;Deng, Haiteng
Clear cell renal cell carcinoma (ccRCC) is a frequently occurring renal cancer. The Von Hippel-Lindau disease tumor suppressor VHL, a known tumor suppressor gene, is frequently mutated in about 50% of patients with ccRCC. However, it is unclear whether VHL influences the progression of ccRCC tumors expressing wild-type VHL. In the present study, we found that higher expression of VHL was correlated with the better disease-free survival (DFS) in ccRCC patients using The Cancer Genome Atlas (TCGA) datasets. We revealed that VHL overexpression in ccRCC cells inhibited epithelial-mesenchymal transition (EMT), sterol regulatory element-binding protein 1 (SREBP1)-regulated triglyceride synthesis, and cell proliferation. Proteomic analysis provided us a global view that VHL regulated four biological processes, including metabolism, immune regulation, apoptosis, and cell movement. Importantly, we found that VHL overexpression led to up-regulated expression of proteins associated with antigen processing and interferon-responsive proteins, thus rendering ccRCC cells more sensitive to interferon treatment. We defined an interferon-responsive signature (IRS) composed of ten interferon-responsive proteins, whose mRNA expression levels were positively correlated with DFS in ccRCC patients. Taken together, our results propose that the subset of ccRCC patients with high VHL expression benefit from immunotherapy.
登录
查看更多内容
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
DOI:
10.1136/bmj.g4797
发表时间:
2014-11-10
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Jonasch E;Gao J;Rathmell WK
通讯作者:
Rathmell WK
影响因子:
4.4
作者:
Hu, Yadong;Wang, Helin;Deng, Haiteng
通讯作者:
Deng, Haiteng
影响因子:
5.4
作者:
Dagher, Julien;Kammerer-Jacquet, Solene-Florence;Rioux-Leclercq, Nathalie
通讯作者:
Rioux-Leclercq, Nathalie
影响因子:
12.8
作者:
Bogunovic, Dusan;Boisson-Dupuis, Stephanie;Casanova, Jean-Laurent
通讯作者:
Casanova, Jean-Laurent